OTCMKTS:AVMXY AVITA MED LTD/S (AVMXY) Stock Price, News & Analysis → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free AVMXY Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$7.89▼$7.8950-Day Range$7.89▼$7.8952-Week Range$1.06▼$8.58VolumeN/AAverage Volume183,275 shsMarket Capitalization$651.87 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get AVITA MED LTD/S alerts: Email Address Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now About AVITA MED LTD/S Stock (OTCMKTS:AVMXY)Avita Medical Limited operates as a regenerative medicine company in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. It offers regenerative products for the treatment of burns, chronic wounds, and aesthetics indications. The company's patented and proprietary collection and application technology provides treatment solutions derived from a patient's own skin. Its lead product, RECELL System, is used in the treatment of various skin defects, such as burns and plastic reconstructive procedures. The company also offers ReGenerCell for chronic wounds and ReNovaCell for the restoration of pigmentation. Avita Medical Limited is based in Valencia, California.Read More Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now AVMXY Stock News HeadlinesApril 23, 2024 | morningstar.comHogy Medical Co LtdApril 12, 2024 | markets.businessinsider.comLake Street Keeps Their Buy Rating on Avita Medical (RCEL)April 25, 2024 | Behind the Markets (Ad)Will this $2 AI stock double overnight?It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!April 11, 2024 | marketwatch.comAvita Medical Shares Fall 6.6% on Revised 1Q Outlook, 2024 Revenue ExpectationsMarch 12, 2024 | msn.comE-Smart Clinic Goes LIVE! A Lord's Mark Initiative for a Healthier India in Collaboration with Government of IndiaMarch 1, 2024 | msn.comMax Healthcare, Aster DM, KIMS shares tank up to 8% today. Here's whyFebruary 17, 2024 | wsj.comSisram Medical Ltd.February 5, 2024 | news.yahoo.comAvita Ontario Hospital first stop on statewide Ohio Adversity and Resilience Study tourApril 25, 2024 | Behind the Markets (Ad)Will this $2 AI stock double overnight?It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!January 10, 2024 | msn.comAvita Medical misses Q4,FY 23 prelim revenue estimateNovember 23, 2023 | morningstar.comAVITA Medical Inc AVHHLNovember 21, 2023 | marketwatch.comAvita Medical Shares Drop After 2023 Commercial Revenue Outlook CutNovember 21, 2023 | msn.comAVITA Medical Cuts Revenue Forecast, Joins iQIYI, Trip.com And Other Big Stocks Moving Lower In Tuesday's Pre-Market SessionNovember 11, 2023 | benzinga.comAVITA Medical Stock (NASDAQ:RCEL), Analyst Ratings, Price Targets, PredictionsOctober 24, 2023 | fool.com.auWhy AVITA Medical, Bellamy's, Evolution, & Volpara shares dropped into the red todayOctober 2, 2023 | msn.comWhy Shares of Avita Medical Are Down MondaySeptember 26, 2023 | markets.businessinsider.comAnalyst Expectations for AVITA Medical's FutureSeptember 1, 2023 | finance.yahoo.comQ2 2023 AVITA Medical Inc Earnings CallJuly 20, 2023 | msn.comAVITA's Balancing Act: RECELL System's Promise Amid Market UncertaintiesMay 14, 2023 | msn.comAvita Medical (ASX:AVH) Price Target Increased by 5.95% to 6.05May 12, 2023 | benzinga.comAVITA Medical shares are trading lower after the company reported mixed Q1 financial results.May 12, 2023 | markets.businessinsider.comPiper Sandler Keeps Their Buy Rating on Avita Medical (RCEL)May 12, 2023 | markets.businessinsider.comHere's what Wall Street expects from AVITA Therapeutics's earnings reportMay 2, 2023 | news.yahoo.comBriefs: Avita medication program, Senior Spring Extravaganza, ODNR honorMarch 19, 2023 | seekingalpha.comAVITA Medical: At A CrossroadsFebruary 26, 2023 | finance.yahoo.comQ4 2022 AVITA Medical Inc Earnings CallFebruary 24, 2023 | benzinga.comAvita Medical shares are trading higher after the company reported better-than-expected Q4 EPS and sales results.See More Headlines Receive AVMXY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AVITA MED LTD/S and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biological Products, Except Diagnostic Sub-IndustryN/A Current SymbolOTCMKTS:AVMXY CUSIPN/A CIKN/A Webwww.avitamedical.com Phone661-367-9170FaxN/AEmployees55Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio5.50 Quick Ratio5.33 Sales & Book Value Annual Sales$5.51 million Price / Sales118.31 Cash FlowN/A Price / Cash FlowN/A Book Value$0.26 per share Price / Book30.35Miscellaneous Outstanding Shares82,620,000Free FloatN/AMarket Cap$651.87 million OptionableNot Optionable Beta1.28 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesDr. Michael S. Perry (Age 60)CEO & Director Mr. Timothy RooneyChief Admin. Officer & Interim CFOMr. Andrew QuickChief Technology OfficerMs. Erin LibertoChief Commercial OfficerMr. Adam KelliherConsultantKey CompetitorsOsiris TherapeuticsOTCMKTS:OSIRCabaletta BioNASDAQ:CABAHilleVaxNASDAQ:HLVXMesoblastNASDAQ:MESONovavaxNASDAQ:NVAXView All Competitors This page (OTCMKTS:AVMXY) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AVITA MED LTD/S Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
